The Leader in Innovative Microbial Identification Methods
2011 Accugenix has identified over unique 2,000 bacterial species with an industry leading 16S rDNA bacterial database of over 4,200 entries, making all competitive bacterial ID databases merely a subset of the Accugenix library.
2011 Accugenix surpasses the one-half million mark for sequencing environmental isolates from over 1,000 pharmaceutical and biotechnology production facilities around the world, allowing us to build the largest, most comprehensive, and most unique databases for bacteria and fungi that occur in manufacturing environments worldwide.
2011 Accugenix offers bacterial strain typing by multi or single locus sequencing as a special project service.
2010 Accugenix develops a cGMP compliant process for making near real-time library additions, providing customers the latest taxonomic species level information. Our database contains 2x more relevant species entries than any other available database on the market. In comparison, other systems are missing half of the encountered species and have many entries that are taxonomically incorrect.
2010 Accugenix introduces AccuPRO-ID®, becoming the first service laboratory to offer cGMP bacterial identifications using a proteotypic method based on MALDI-TOF mass spectrometry technology. This service provides bacterial identification to the species level with greater accuracy than outdated phenotypic methods.
2009 Accugenix is the first service laboratory to provide comparative DNA sequencing for fungal samples using the Internal Transcribed Spacer (ITS) region. The ITS region is now widely accepted as the “gold standard” by fungal taxonomists for species identification.
2008 Accugenix initiates a research program for the development of a bacterial strain typing service utilizing multi and single locus (MLST and SLST) sequencing for bacterial strain typing.
2005 Accugenix develops and validates its proprietary 16S rDNA library database and discontinues the use of the MicroSEQ® v 2.0 library to achieve greater accuracy, improve compliance and produce timelier library additions.
2005 Corporate name changes from “Acculab, Inc.” to “Accugenix, Inc.” on February 25, 2005 commemorating the replacement of outdated fatty acid analysis with the improved accuracy, repeatability and speed of DNA sequencing for microbial identification.
2002 Accugenix begins offering DNA fingerprinting service for bacterial strain typing using DuPont Qualicon’s RiboPrinter®
1999 “Accugenix, a Division of Acculab, Inc.” is launched to reflect the addition of comparative DNA sequencing to our menu of validated methods.
1997 The commercial DNA sequencing system, MicroSEQ® was developed by our CEO, Doug Smith while at Applied Biosystems.
1990 “Acculab, Inc.,” a reference laboratory specializing in microbial identification for industry and research clients is founded. Acculab is one of the first service laboratories in the world to offer cellular fatty acid analysis for pharmaceutical Environmental Monitoring Programs.
1987 The commercial Fatty Acid Microbial Identification System was developed by our CEO, Doug Smith while working at Hewlett-Packard/Agilent.
